[PROWESS--milestone in lowering sepsis mortality].
Reinhart
Konrad
K
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D015337:Multicenter Studies as Topic; D011486:Protein C / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use*; D012772:Shock, Septic / Q000188:drug therapy / Q000401:mortality / Q000451:nursing*; D015996:Survival Rate; D018746:Systemic Inflammatory Response Syndrome / Q000188:drug therapy / Q000401:mortality / Q000451:nursing*
D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D005343:Fibrinolytic Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated